What is the most effective strategy to reduce the risk of stroke recurrence in neoplastic vasculitis?
Treating the underlying malignancy is the most effective strategy to reduce the risk of stroke recurrence in neoplastic vasculitis. This has been supported by a large meta-analysis of cases of angiotropic lymphoma reported between 1957 and 2012, where only 8% of cases presented with stroke-like symptoms. Even though limited information is available on how to reduce the risk of stroke recurrence, treating the underlying malignancy is still the advised approach.